2.22

11.20% -0.28

After Hours: 2.30 0.08 +3.60%

Serina Therapeutics Inc (SER)

Overview News Price History Discussions Forecast

Serina Therapeutics Inc stock is traded at $2.22, with a volume of 69,292. It is down -11.20% in the last 24 hours and down -20.14% over the past month. Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.

Previous Close:

$2.50

Open:

$2.41

24h Volume:

69,292

Relative Volume:

0.89

Market Cap:

$56.39M

Revenue:

$130.00K

Net Income/Loss:

$-21.29M

P/E Ratio:

-1.1229

EPS:

-1.977

Net Cash Flow:

$-18.29M

1W Performance:

-18.68%

1M Performance:

-20.14%

6M Performance:

+48.00%

1Y Performance:

-56.47%

1-Day Range:

$2.20

$2.54

1-Week Range:

$2.20

$2.78

52-Week Range:

$1.22

$5.83

Serina Therapeutics Inc Stock (SER) Company Profile

Name

Serina Therapeutics Inc

Sector

Healthcare (1069)

Industry

Biotechnology (595)

Phone

(256) 327-9630

Address

601 GENOME WAY, HUNTSVILLE

Employee

Twitter

Next Earnings Date

2026-08-17

Latest SEC Filings

SER's Discussions on Twitter

Compare SER vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SER Serina Therapeutics Inc	2.22	56.39M	130.00K	-21.29M	-18.29M	-1.977
VRTX Vertex Pharmaceuticals Inc	515.44	130.64B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	781.49	80.46B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	984.39	61.58B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	143.97	57.48B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	203.77	43.68B	742.00K	-1.37B	-1.07B	-7.0731

Serina Therapeutics Inc Stock (SER) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-14-25	Initiated	H.C. Wainwright	Buy

Serina Therapeutics Inc Stock (SER) Latest News

Sep 11, 2026

Serina Therapeutics at H.C. Wainwright conference: Parkinson’s push advances By Investing.com - Investing.com Canada

Sep 11, 2026

Serina Therapeutics at H.C. Wainwright conference: Parkinson’s push advances - Investing.com India

Sep 11, 2026

Sep 10, 2026

Serina Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference - The Manila Times

Sep 10, 2026

Serina Therapeutics will present its neurological disease work Sept. 14. - Stock Titan

Sep 10, 2026

Sep 09, 2026

Serina Therapeutics Announces Independent Committee Recommends Advance of SER-252 Parkinson’s Study to Cohort 2 - Quiver Quantitative

Sep 09, 2026

Some Parkinson’s patients showed sustained motor improvement in Serina’s study - Stock Titan

Sep 09, 2026

Sep 05, 2026

Should I Buy SER? SER 2026 AnalysisIntellectia AI™ - intellectia.ai

Sep 05, 2026

Sep 02, 2026

Serina Therapeutics (SER) Dips 2.40% to $2.44, Testing Key Support at $2.32Block Trade Flow - vinanet.vn

Sep 02, 2026

Sep 01, 2026

Serina Therapeutics, Inc. SEC Filing (Sep 1, 2026) - Stock Titan

Sep 01, 2026

Aug 28, 2026

Serina Therapeutics Establishes Flexible Equity Financing Agreement - The Globe and Mail

Aug 28, 2026

Aug 27, 2026

Serina Therapeutics Secures $25 Million Equity Financing Facility with Roth Principal - Minichart

Aug 27, 2026

Serina Therapeutics Sets Up $25 Million Equity Purchase Facility With Roth Principal Investments - TradingView

Aug 27, 2026

Aug 25, 2026

IPO Databook: Serina Therapeutics (SER US)Aug 2026 - Smartkarma

Aug 25, 2026

Aug 24, 2026

Serina TherapeuticsOffers Up To 12,500,000 Shares Of Common Stock By Roth Principal InvestmentsSEC Filing - TradingView

Aug 24, 2026

Aug 20, 2026

BTIG Maintains Serina Therapeutics(SER.US) With Buy Rating, Maintains Target Price $8 - Moomoo

Aug 20, 2026

Serina Therapeutics, Inc. announced that it expects to receive $25 million in funding from Roth Principal Investments, LLC - marketscreener.com

Aug 20, 2026

Aug 19, 2026

Serina (SER) Move: Ends Lower by 1.53% at $2.58 in the Latest Reading; Next Session: the Near-Term Reference Band Stretches From $2.45 to $2.71 in the Available RecordSwing Entry Signals - vinanet.vn

Aug 19, 2026

Aug 13, 2026

Serina Therapeutics Q2 loss widens to $(0.55) as revenue drops to zero - scanx.trade

Aug 13, 2026

Serina Therapeutics Completes Dosing for 8 Parkinson’s Patients - Stock Titan

Aug 13, 2026

Serina Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 13, 2026

Serina Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates - Yahoo Finance

Aug 13, 2026

Aug 10, 2026